202 related articles for article (PubMed ID: 25576059)
1. A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism.
Cook JR; Matsumoto M; Banks AS; Kitamura T; Tsuchiya K; Accili D
Diabetes; 2015 Jun; 64(6):1951-65. PubMed ID: 25576059
[TBL] [Abstract][Full Text] [Related]
2. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
[TBL] [Abstract][Full Text] [Related]
3. Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation.
Ido-Kitamura Y; Sasaki T; Kobayashi M; Kim HJ; Lee YS; Kikuchi O; Yokota-Hashimoto H; Iizuka K; Accili D; Kitamura T
PLoS One; 2012; 7(10):e47231. PubMed ID: 23056614
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
[TBL] [Abstract][Full Text] [Related]
5. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
[TBL] [Abstract][Full Text] [Related]
7. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.
Haeusler RA; Hartil K; Vaitheesvaran B; Arrieta-Cruz I; Knight CM; Cook JR; Kammoun HL; Febbraio MA; Gutierrez-Juarez R; Kurland IJ; Accili D
Nat Commun; 2014 Oct; 5():5190. PubMed ID: 25307742
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice.
Banks AS; Kim-Muller JY; Mastracci TL; Kofler NM; Qiang L; Haeusler RA; Jurczak MJ; Laznik D; Heinrich G; Samuel VT; Shulman GI; Papaioannou VE; Accili D
Cell Metab; 2011 Nov; 14(5):587-97. PubMed ID: 22055502
[TBL] [Abstract][Full Text] [Related]
9. Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner.
Choi D; Oh KJ; Han HS; Yoon YS; Jung CY; Kim ST; Koo SH
Hepatology; 2012 Oct; 56(4):1546-56. PubMed ID: 22532369
[TBL] [Abstract][Full Text] [Related]
10. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.
Titchenell PM; Chu Q; Monks BR; Birnbaum MJ
Nat Commun; 2015 May; 6():7078. PubMed ID: 25963408
[TBL] [Abstract][Full Text] [Related]
11. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.
Zhang K; Li L; Qi Y; Zhu X; Gan B; DePinho RA; Averitt T; Guo S
Endocrinology; 2012 Feb; 153(2):631-46. PubMed ID: 22147007
[TBL] [Abstract][Full Text] [Related]
12. Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity.
Chu Y; Gómez Rosso L; Huang P; Wang Z; Xu Y; Yao X; Bao M; Yan J; Song H; Wang G
Cell Res; 2014 Oct; 24(10):1250-65. PubMed ID: 25223702
[TBL] [Abstract][Full Text] [Related]
13. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.
Lu M; Wan M; Leavens KF; Chu Q; Monks BR; Fernandez S; Ahima RS; Ueki K; Kahn CR; Birnbaum MJ
Nat Med; 2012 Feb; 18(3):388-95. PubMed ID: 22344295
[TBL] [Abstract][Full Text] [Related]
14. Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia.
Haeusler RA; Han S; Accili D
J Biol Chem; 2010 Aug; 285(35):26861-26868. PubMed ID: 20573950
[TBL] [Abstract][Full Text] [Related]
15. FoxO1 links hepatic insulin action to endoplasmic reticulum stress.
Kamagate A; Kim DH; Zhang T; Slusher S; Gramignoli R; Strom SC; Bertera S; Ringquist S; Dong HH
Endocrinology; 2010 Aug; 151(8):3521-35. PubMed ID: 20501674
[TBL] [Abstract][Full Text] [Related]
16. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin Gallate Inhibits Hepatic Glucose Production in Primary Hepatocytes via Downregulating PKA Signaling Pathways and Transcriptional Factor FoxO1.
Li X; Chen Y; Shen JZ; Pan Q; Yang W; Yan H; Liu H; Ai W; Liao W; Guo S
J Agric Food Chem; 2019 Apr; 67(13):3651-3661. PubMed ID: 30875211
[TBL] [Abstract][Full Text] [Related]
19. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.
Puigserver P; Rhee J; Donovan J; Walkey CJ; Yoon JC; Oriente F; Kitamura Y; Altomonte J; Dong H; Accili D; Spiegelman BM
Nature; 2003 May; 423(6939):550-5. PubMed ID: 12754525
[TBL] [Abstract][Full Text] [Related]
20. Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling.
Langlet F; Haeusler RA; Lindén D; Ericson E; Norris T; Johansson A; Cook JR; Aizawa K; Wang L; Buettner C; Accili D
Cell; 2017 Nov; 171(4):824-835.e18. PubMed ID: 29056338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
